Straub Medical AG is the world leader in the manufacture of systems for mechanical intravascular thrombectomy.
The idea of mechanical intravascular thrombectomy was born in the early 90s. In 1995, a patent of the Rotarex system was obtained. In 1999, the system received CE Mark for the Rotarex system. In 2004-2005, the Aspirex system was patented and received the CE Mark system.
Currently, the company produces and exports products to more than 50 countries. Straub Medical AG does not stop the development of new products and the improvement of existing models, the emphasis is on improving efficiency, safety, as well as reducing the time of the operation.
Description:
Rotarex ® S is a highly effective agent for acute and chronic occlusions:
- Native vessels
- Stent
- Shunts
- Dialysis access
Four functions of one device:
- Destruction of the occlusive material in the vessel
- Aspiration of material inside the catheter
- Fragmentation of aspirated material
- Removal from the vessel
Advantages:
Rotarex ® S removes all occlusive material - in both acute and chronic cases - and opens up a problematic site.
- Long stents are not needed
- Prevents distal embolism
- Does not require the use of thrombolytics
- Does not cause hemolysis
- Reduces patient risk
- Reduces the cost of the procedure
Rotarex ® S allows the destruction of neointima and reduces the risk of additional measures.
All Straub Medical catheters are driven by a single drive.
- Simple assembly
- During operation, there is no need for physiological saline solution
- Magnetic catheter connection
- Control by means of a manual or footswitch
- Fully electronic
- Reliable and secure
The mechanical drive consists of a motor, a control unit, a footswitch, a transport package.